Forsteo

DRUG5 trials

Sponsors

Novartis, Nottingham University Hospitals NHS Trust, Seoul National University Bundang Hospital, Shenzhen Salubris Pharmaceuticals Co., Ltd.

Conditions

Fracture, AnkleOsteoporosisPost-menopausal OsteoporosisPostmenopausal OsteoporosisSpine Deformity

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

CompletedNCT01224717

NovartisPost-menopausal Osteoporosis

Start: 2010-09-30Updated: 2011-05-13

Nasally and sc Administered Teriparatide in Healthy Volunteers

Nottingham University Hospitals NHS TrustOsteoporosis

Start: 2013-09-30End: 2014-08-31Target: 7Updated: 2013-08-01

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

CompletedNCT04747392

Shenzhen Salubris Pharmaceuticals Co., Ltd.Postmenopausal Osteoporosis

Start: 2020-08-19End: 2020-11-11Updated: 2021-02-10

Phase 4

Ankle Fractures Treated With Teriparatide

Nottingham University Hospitals NHS TrustFracture, Ankle

Start: 2016-10-31End: 2017-10-31Target: 10Updated: 2016-11-04

Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial

Seoul National University Bundang HospitalSpine Deformity

Start: 2014-01-01End: 2020-12-31Updated: 2020-01-27